Martin Dow Healthcare is a full-service CDMO based in France. Founded in 2015, we are serving as a one-stop solution for Nutraceutical companies throughout Europe and beyond, solving their challenges and taking their brands to brighter horizons.
We devote our expertise to the development, manufacture, and commercialization of bespoke nutraceuticals while our support extends to the management of various commercial-level projects for global clients.
Branching out under the Martin Dow Group, a multinational healthcare group, we benefit our partners with widespread access to Asian, European, and African regions.
To meet the ever-increasing expectations of our consumers and partners, we are expanding and integrating newer technologies and certifications under our brand. This enables our partners to benefit from our extensive portfolio of private labels, customized services, and scientific knowledge.
Martin Dow Healthcare maintains a client-focused culture and the success of our partners is a priority for us. Hence, we place the highest priority on the safety and efficacy of our products to build the highest trust of our clients.
Site is renovated
Conducted trial manufacturing
Equipped with new Machines for dry form
Start of production in dry form
Renovation and beginning of the liquid form
Start of soft gel manufacturing
We operate our business under demanding corporate standards that symbolize our ethical principles. We have embarked on a journey of creating long-term value for our consumers and employees and our beliefs reflect our devotion to preserving the fabric of trust.
Creativity and originality lie at the core of our business. We aim to deliver ideas that not only meet customer demands in unique ways but also generate the highest value for our business partners.
We are dedicated to developing cost-effective ideas, that are replicable on a commercial scale and translatable into high-value nutraceutical solutions.
We take care of our customer’s needs by consistently delivering them products that perform at the highest level of efficacy. We succeed at offering them bespoke options that are cost-effective and personalized to their satisfaction.
We are devoted to delivering them professional assistance that lies beyond value addition and emphasizes the preservation of long-term relationships.
We consider our employees essential to our success. We do everything in our power, from designing, operating, to installing workspaces to maintain their optimal health and safety.
Sustainable development, the conservation of the environment, reduction of accidents and pollutants also lie at the top of our priorities. As a business, we are committed to the needs of current & future generations.
Ali Akhai became the Chairman, Martin Dow Group in October 2018. As an initiative-driven leader, he believes in the significance of diverse business, technological innovation, and talent, ready to lead impact with a desire to enhance the wellbeing of the human race. He is recognized as the face of the Martin Dow Group and has received praise for his in-depth knowledge of numerous facets of the pharmaceutical industry.
After completing his Bachelor of Science business graduate degree (BSc) from Brunel University in the UK, he proceeded to further his education with a double Master's degree. He holds a Master of Science in Global Business from the University of Hertfordshire in the United Kingdom and a Master of Science in International Business Development & Consulting from Novancia Business School in France.
Ali joined the Martin Dow Group of Companies in 2016, and after completing a structured orientation program in Marketing, Finance, Business Development, Human Resources, and Regulatory Affairs, he assumed the role of Business Development Lead, launching eight new items for the Group by mid-2018.
He is playing an essential role in shaping the future of the Martin Dow Group, carrying on his father's vision by guiding the Group's foray into further diversification through successful strategic acquisitions and flexible technologies. As Chairman of the Group, he is leading the 6th Largest Pharmaceutical Group in Pakistan with 2 Healthcare Companies in Europe, into expansion with worldwide partnerships, talent development, and industry influence, to ethically grow through innovation and courage.
He is a visionary and philanthropist, deeply focused on improving the standards of Healthcare, Education and Environment in Pakistan. He represents Pakistan in global events such as World Economic Forum, closely working with global and local key stakeholders to present the Nation’s interest and enhance Pakistan’s international reputation.
Javed is a Group Managing Director and Chief Executive Officer of Martin Dow Group, and under his leadership, the group has experienced unprecedented growth, including the acquisition of the Roche brands and manufacturing facility, leading the Group's growth further through his noteworthy insights.
He is a qualified fellow member of the Institute of Cost & Management Accountants of Pakistan, with over 25 years of experience leading in diversified functions such as Finance, Marketing, International Business, Business Development, Supply Chain, Regulatory Affairs, New Product Development, and Technical Functions.
He has held key positions at a number of leading multinational and national companies, including Abbott Laboratories, Getz Pharma, Briogene, and AJ Research & Pharma (a Saudi Arabian subsidiary of the Al Jomiah Group), the latter two of which he served as the Chief Executive Officer (CEO).
To his credit, he has grown AJ Pharma from a start-up to a global company with a strong presence in both prescription and consumer health markets across seven ASEAN and GCC countries. Under his guidance, the Martin Dow Group continues to grow and set new standards of distinction across the healthcare and pharmaceutical industry in Pakistan and abroad.
Dr. Munir Anwar is working with Martin Dow with a journey of excellence spanning over 40 years in General Management & technical functions including 25 years in multinational organizations such as GSK, Bristol-Myers Squibb, Boots & Eli Lilly. He is highly skilled in technical operations and General Management. He has work experience of international operations.With extensive training from national and international institutes and vast experience with eminent pharmaceutical companies, Dr. Anwar has been recognized and acknowledged as an expert in today’s Healthcare industry and possesses distinctives charisma which leads to effective implementations of strategic vision of the company.
Aoife Gallaghar is in charge of all legal, tax, HR & administration matters for Martin Dow Healthcare (& Martin Dow Pharmaceuticals). Aoife has over 20 years’ experience in corporate, employment, commercial, fiscal & IP law. Prior to joining Martin Dow Healthcare in 2015, she worked as an Attorney at Law (admitted to the Paris Bar) and has worked in both private practice with major international law firms such as Hoche & Salans, (now operating as Dentons) as well as in-house with Chanel and Dim Branded Apparel (a Sara Lee Spin off).
Guillaume Huguet is in charge of all Finance and IT maters for Martin Dow Healthcare.Guillaume joined Martin Dow Healthcare in 2018. He has over 18 years’ experience in Finance acquired within international companies such as IBM, Allianz and DXC Technology and was previously CFO of a small and medium size manufacturing company in food industry
Philippe Alphonse joined the Martin Dow Group after a 25-year experience in the pharmaceutical market. 10 years of function of commercial direction in the distribution of food supplements in pharmacy. 15 years of Sales and Marketing in leading companies on the design and manufacture of food supplements. Philippe Alphonse is recognized as an expert on the market of food supplements and actors.
Our success is solely dependent on the growth of our clients' diverse businesses. Our success model is our ability to handle distinct clients in unique ways. We meet private label production needs by streamlining the product development journey with comprehensive solutions at each stage of the process. We are expanding and growing into new markets, tackling private label manufacturing for European, African, and Asian businesses, as well as successfully serving laboratories, manufacturers, channel partners, and individual patent holders. Our clients' trust in us reflects the outstanding quality of our one-of-a-kind products and services.
Our certification reflects our commitment to the highest quality standards.
FR 
EN 